News German agency refuses to rule on drug’s benefits until Pfizer discloses all trial results BMJ 2009; 338 doi: https://doi.org/10.1136/bmj.b2521 (Published 22 June 2009) Cite this as: BMJ 2009;338:b2521 Article Related content Metrics Responses Peer review Related articles Editorial Rationing new medicines in the UK Published: 22 January 2009; BMJ 338 doi:10.1136/bmj.a3182 News In brief Published: 09 December 2009; BMJ 339 doi:10.1136/bmj.b5350 Analysis Finding studies on reboxetine: a tale of hide and seek Published: 12 October 2010; BMJ 341 doi:10.1136/bmj.c4942 Research Searching for unpublished data for Cochrane reviews: cross sectional study Published: 23 April 2013; BMJ 346 doi:10.1136/bmj.f2231 See more Communicating risk to patients in the emergency department BMJ December 05, 2016, 355 i6437; DOI: https://doi.org/10.1136/bmj.i6437 Biological treatment is approved for severe eosinophilic asthma BMJ December 01, 2016, 355 i6472; DOI: https://doi.org/10.1136/bmj.i6472 Patient care is at risk from lack of new funds in autumn statement, healthcare leaders warn BMJ November 24, 2016, 355 i6356; DOI: https://doi.org/10.1136/bmj.i6356 Government must be clearer in its claims about NHS funding, says statistics watchdog BMJ November 24, 2016, 355 i6340; DOI: https://doi.org/10.1136/bmj.i6340 US must address addiction as an illness, not as a moral failing, Surgeon General says BMJ November 22, 2016, 355 i6265; DOI: https://doi.org/10.1136/bmj.i6265 Cited by... Searching for unpublished data for Cochrane reviews: cross sectional studyAbstract Fulltext PDF A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable populationAbstract Fulltext PDF Finding studies on reboxetine: a tale of hide and seekAbstract Fulltext PDF
